tiprankstipranks
Trending News
More News >
Sumitomo Dainippon Pharma Co (DNPUF)
:DNPUF
US Market

Sumitomo Dainippon Pharma Co (DNPUF) Financial Statements

Compare
8 Followers

Sumitomo Dainippon Pharma Co Financial Overview

Sumitomo Dainippon Pharma Co's market cap is currently $2.86B. The company's EPS TTM is $0.0423776; its P/E ratio is 17.24; Sumitomo Dainippon Pharma Co is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 398.83B¥ 314.56B¥ 555.54B¥ 560.03B¥ 515.95B
Gross Profit¥ 245.40B¥ 187.98B¥ 376.63B¥ 402.91B¥ 378.18B
Operating Income¥ 14.93B¥ -354.19B¥ -76.98B¥ 60.23B¥ 71.22B
EBITDA¥ 57.58B¥ -281.07B¥ -3.50B¥ 124.36B¥ 103.11B
Net Income¥ 23.63B¥ -314.97B¥ -74.51B¥ 56.41B¥ 56.22B
Balance Sheet
Cash & Short-Term Investments¥ 23.12B¥ 29.05B¥ 163.65B¥ 238.58B¥ 223.18B
Total Assets¥ 742.60B¥ 907.51B¥ 1.13T¥ 1.31T¥ 1.31T
Total Debt¥ 305.42B¥ 418.88B¥ 334.72B¥ 269.05B¥ 273.82B
Net Debt¥ 282.31B¥ 389.84B¥ 191.24B¥ 66.06B¥ 80.12B
Total Liabilities¥ 573.13B¥ 751.37B¥ 727.96B¥ 634.44B¥ 659.95B
Stockholders' Equity¥ 169.48B¥ 156.06B¥ 406.75B¥ 607.89B¥ 580.57B
Cash Flow
Free Cash Flow¥ 8.00B¥ -257.62B¥ -805.00M¥ 17.75B¥ 124.80B
Operating Cash Flow¥ 16.50B¥ -241.89B¥ 11.94B¥ 31.24B¥ 135.60B
Investing Cash Flow¥ 99.75B¥ 33.04B¥ 52.42B¥ -18.28B¥ 8.88B
Financing Cash Flow¥ -108.84B¥ 77.85B¥ -146.82B¥ -21.43B¥ -57.22B
Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History

Sumitomo Dainippon Pharma Co Debt to Assets

Sumitomo Dainippon Pharma Co Cash Flow

Sumitomo Dainippon Pharma Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis